跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
UPLIZNA inebilizumab 100 mg/10 mL concentrated injection vial
Approved
STANDARD
UPLIZNA inebilizumab 100 mg/10 mL concentrated injection vial
Amgen Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
859b6a7b880d0c33
Company
Amgen Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
859b6a7b880d0c33
Product Name
UPLIZNA inebilizumab 100 mg/10 mL concentrated injection vial
Artg Id
446050
Artg Name
UPLIZNA inebilizumab 100 mg/10 mL concentrated injection vial
Sponsor
Amgen Australia Pty Ltd
Company Detail Path
/organization/amgen-australia-pty-ltd
Artg Date
2025-03-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
859b6a7b880d0c33
Type
Standard
Back to TGA Approvals
UPLIZNA inebilizumab 100 mg/10 mL concentrated injection vial - TGA Drug Approval Details
